The DPP Covid-19 IgM/IgG system is a single-use rapid point-of-care test for the detection and differentiation of IgM and IgG antibodies to covid-19 in whole blood.
Read More
The agency’s EUA grants permission for Cepheid’s test to be used in high- and moderate-complexity CLIA-certified laboratories as well as in certain patient care settings.
Read MoreOlo, a compact blood analyzer from Sight Diagnostics, Tel Aviv, Israel, has been installed in Sheba Tel Hashomer’s special quarantined lab to support the management of coronavirus patients.
Read More
MBio partners with SRI International on diagnostic programs funded by BARDA.
Read MoreBuilding upon the existing Accula molecular platform, Mesa’s coronavirus test aims to deliver accurate and accessible testing close to the patient, providing critical information to healthcare providers in China, the United States, and other affected countries
Read More